Serum markers of infections in patients with primary biliary cirrhosis: Evidence of infection burden

Experimental and Molecular Pathology

Volumn 93, Issue 3, 2012, Pages 386-390

  Shapira, Yinon ^a   Agmon Levin, Nancy ^a   Renaudineau, Yves ^a,b   Porat Katz, Bat Sheva ^c   Barzilai, Ori ^a   Ram, Maya ^a   Youinou, Pierre ^a,b   Shoenfeld, Yehuda ^a,d  

^a Universite de Brest   (France)

^b BREST UNIVERSITY HOSPITAL   (France)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cytomegalovirus; Epstein Barr virus; Helicobacter pylori; Infection; PBC; Toxoplasmosis

Indexed keywords

ANTIBODY; BACTERIUM ANTIBODY; CYTOMEGALOVIRUS ANTIBODY; EPSTEIN BARR VIRUS ANTIGEN; MITOCHONDRION ANTIBODY; PARASITE ANTIBODY; TOXOPLASMA GONDII ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DISEASE MARKER; EPSTEIN BARR VIRUS; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATHOGEN LOAD; PRIMARY BILIARY CIRRHOSIS; RISK ASSESSMENT; RISK FACTOR; SEROPREVALENCE; TOXOPLASMA GONDII;

ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; VIRUS DISEASES;

CYTOMEGALOVIRUS; HELICOBACTER PYLORI; HEPATITIS C VIRUS; HUMAN HERPESVIRUS 4; TOXOPLASMA GONDII;

EID: 84870684854     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2012.09.012     Document Type: Article

References (48)

1. Abdulkarim A.S., Petrovic L.M., Kim W.R., Angulo P., Lloyd R.V., Lindor K.D. Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumonia?. Journal of Hepatology 2004, 40:380-384.
2. Agmon-Levin N., Katz B.S., Shoenfeld Y. Infection and primary biliary cirrhosis. The Israel Medical Association Journal 2009, 11:112-115.
3. Agmon-Levin N., Ram M., Barzilai O., Porat-Katz B.S., Parikman R., Selmi C., et al. Prevalence of hepatitis C serum antibody in autoimmune diseases. Journal of Autoimmunity 2009, 32:261-266.
4. Agmon-Levin N., Shapira Y., Selmi C., Barzilai O., Ram M., Szyper-Kravitz M., et al. A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis. Journal of Autoimmunity 2010, 34:55-58.
5. Arnson Y., Amital H., Guiducci S., Matucci-Cerinic M., Valentini G., Barzilai O., Ram M., Shoenfeld Y. The role of infections in the immunopathogensis of systemic sclerosis-evidence from serological studies. Annals of the New York Academy of Sciences 2009, 1173:627-632.
6. Barzilai O., Sherer Y., Ram M., Izhaky D., Anaya J.M., Shoenfeld Y. Epstein-Barr virus and cytomegalovirus in autoimmune diseases. Are they truly notorious? A preliminary report. Annals of the New York Academy of Sciences 2007, 1108:567-577.
7. Berkun Y., Zandman-Goddard G., Barzilai O., Boaz M., Sherer Y., Larida B., et al. Infectious antibodies in systemic lupus erythematosus patients. Lupus 2009, 18:1129-1135.
8. Bogdanos D.P., Baum H., Grasso A., Okamoto M., Butler P., Ma Y., et al. Microbial mimics are major targets of cross reactivity with human pyruvate dehydrogense in primary biliary cirrhosis. Journal of Hepatology 2004, 40:31-39.
9. Carlens C., Jacobsson L., Brandt L., Cnattingius S., Stephansson O., Askling J. Perinatal characteristics, early life infections, and later risk of rheumatoid arthritis and juvenile idiopathic arthritis. Annals of the Rheumatic Diseases 2009, 68:1159-1164.
10. Durazzo M., Rosina F., Premoli A., Morello E., Fagoonee S., Innarella R., et al. Lack of association between sero-prevalence of Helicobacter pylori infection and primary biliary cirrhosis. World Journal of Gastroenterology 2004, 10:3179-3181.
11. Epstein S.E., Zhu J., Amir H., Burnett N., Burnett M.S. Insights into the role of infection in atherogenesis and in plaque rupture. Circulation 2009, 119:3133-3141.
12. Eriksson C., Kokkonen H., Johansson M., Hallmans G., Wadell G., Rantapaa-Dahlqvist S. Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden. Arthritis Research & Therapy 2011, 13:R30.
13. Fleige T., Fischer K., Ferguson D.J., Gross U., Bohne W. Carbohydrate metabolism in the Toxoplasma gondii apicoplast: localization of three glycolytic isoenzymes, the single pyruvate dehydrogenase complex, and a plastid phosphate translocator. Eukaryotic Cell 2007, 6:984-996.
14. Gershwin M.E., Selmi C., Worman H.J., Gold E.B., Watnik M., Utts J., et al. Risk factors and comorbidities in primary biliary cirrhosis: a control interview-based study of 1032 patients. Hepatology 2005, 42:1194-1202.
15. Grossman C., Dovrish Z., Shoenfeld Y., Amital H. Do infections facilitate the emergence of systemic sclerosis?. Autoimmunity Reviews 2011, 10(5):244-247.
16. Hirschfield G.M., Gershwin M.E. Primary biliary cirrhosis: one disease with many faces. The Israel Medical Association Journal 2011, 13:55-59.
17. Kaplan M.M., Gershwin M.E. Primary biliary cirrhosis. The New England Journal of Medicine 2005, 353:1261-1273.
18. Kivity S., Agmon-Levin N., Blank M., Shoenfeld Y. Infections and autoimmunity-friends or foes?. Trends in Immunology 2009, 30:409-414.
19. Klutts J.S., Liao R.S., Dunne W.M., Gronowski A.M. Evaluation of a multiplexed bead assay for assessment of Epstein-Barr virus immunologic status. Journal of Clinical Microbiology 2004, 42:4996-5000.
20. Lennette E.T. Epstein-Barr virus. Manual of Clinical Microbiology 2003, vol. 2. ASM Press, Washington, DC. 8th ed. P.R. Murray, E.J. Baron, J.H. Jorgensen (Eds.).
21. Lidar M., Langevitz P., Barzilai O., Ram M., Porat-Katz B.S., Bizzaro N., et al. Infectious serologies and autoantibodies in inflammatory bowel disease: insinuations at a true pathogenic role. Annals of the New York Academy of Sciences 2009, 1173:640-648.
22. Lidar M., Lipschitz N., Langevitz P., Barzilai O., Ram M., Porat-Katz B.S., et al. Infectious serologies and autoantibodies in Wegener's granulomatosis and other vasculitides: novel associations disclosed using the Rad BioPlex 2200. Annals of the New York Academy of Sciences 2009, 1173:649-657.
23. MacSween R.N., Galbraith I., Thomas M.A., Watkinson G., Ludlam G.B. Phytohaemagglutinin (PHA) induced lymphocyte transformation and Toxoplasma gondii antibody studies in primary biliary cirrhosis. Evidence of impaired cell-mediated immunity. Clinical and Experimental Immunology 1973, 15:35-42.
24. Mattner J., Savage P.B., Leung P., Oertelt S.S., Wang V., Trivedi O., et al. Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host & Microbe 2008, 3:304-315.
25. Miyakawa H., Tanaka A., Kikuchi K., Matsushita M., Kitazawa E., Kawaguchi N., et al. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology 2001, 34:243-248.
26. Miyakawa H., Tanaka A., Selmi C., Hosoya N., Mataki N., Kikuchi K., et al. Serum reactivity against bacterial pyruvate dehydrogenase: increasing the specificity of anti mitochondrial antibodies for the diagnosis of primary biliary cirrhosis. Clinical and Developmental Immunology 2006, 13:289-294.
27. Morshed S.A., Nishioka M., Saito I., Komiyama K., Moro I. Increased expression of Epstein-Barr virus in primary biliary cirrhosis patients. Gastroenterologia Japonica 1992, 27:751-758.
28. Ortega-Hernandez O.D., Levin N.A., Altman A., Shoenfeld Y. Infectious agents in the pathogenesis of primary biliary cirrhosis. Disease Markers 2010, 29:277-286.
29. Pender M.P. Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends in Immunology 2003, 24:584-588.
30. Ram M., Anaya J.M., Barzilai O., Izhaky D., Porat Katz B.S., Blank M., Shoenfeld Y. The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders. Autoimmunity Reviews 2008, 7:621-625.
31. Selmi C., Gershwin E.M. Bacteria and human autoimmunity: the case of primary biliary cirrhosis. Current Opinion in Rheumatology 2004, 16:406-410.
32. Selmi C., Gershwin M.E. The role of environmental factors in primary biliary cirrhosis. Trends in Immunology 2009, 30:415-420.
33. Selmi C., Zuin M., Bowlus C.L., Gershwin M.E. Anti-mitochondrial antibody-negative primary biliary cirrhosis. Clinics in Liver Disease 2008, 12:173-185.
34. Selmi C., Lleo A., Pasini S., Zuin M., Gershwin M.E. Innate immunity and primary biliary cirrhosis. Current Molecular Medicine 2009, 9:45-51.
35. Selmi C., De Santis M., Cavaciocchi F., Gershwin M.E. Infectious agents and xenobiotics in the etiology of primary biliary cirrhosis. Disease Markers 2010, 29:287-299.
36. Selmi C., Meda F., Kasangian A., Invernizzi P., Tian Z., Lian Z., Podda M., Gershwin M.E. Experimental evidence on the immunopathogenesis of primary biliary cirrhosis. Cellular and molecular immunology 2010, 7:1-10.
37. Shapira Y., Agmon-Levin N., Selmi C., Petríková J., Barzilai O., Ram M., et al. Prevalence of anti-toxoplasma antibodies in patients with autoimmune diseases. Journal of Autoimmunity 2012, 39(1-2):112-116.
38. Shimoda S., Nakamura M., Shigematsu H., Tanimoto H., Gushima T., Gershwin M.E., Ishibashi H. Mimicry peptides of human PDC-E2 163-176 peptides, the immunodominant T-cell epitope of primary biliary cirrhosis. Hepatology 2000, 31:1212-1216.
39. Shimoda S., Miyakawa H., Nakamura M., Ishibashi H., Kikuchi K., Kita H., et al. CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis. Journal of Autoimmunity 2008, 31:110-115.
40. Tanaka A., Prindiville T.P., Gish R., Solnick J.V., Coppel R.L., Keeffe E.B., et al. Are infectious agents involved in primary biliary cirrhosis? A PCR approach. Journal of Hepatology 1999, 31:664-671.
41. Tanimoto H., Shimoda S., Nakamura M., Ishibashi H., Kawano A., Kamihira T., et al. Promiscuous T cells selected by Escherichia coli: OGDC-E2 in primary biliary cirrhosis. Journal of Autoimmunity 2003, 20:255-263.
42. Taylor-Robinson D., Sharif A.W., Dahanjal N.S., Taylor-Robinson S.D. Chlamydia pneumoniae infection is an unlikely cause of primary biliary cirrhosis. Journal of Hepatology 2005, 42:778-780.
43. Toghill P.J., Williams R., Stern H. Cytomegalovirus infection in chronic liver disease. Gastroenterology 1969, 56:936-937.
44. Tozzoli R., Barzilai O., Ram M., Villalta D., Bizzaro N., Sherer Y., Shoenfeld Y. Infections and autoimmune thyroid diseases: parallel detection of antibodies against pathogens with proteomic technology. Autoimmunity Reviews 2008, 8:112-115.
45. Triger D.R., Kurtz J.B., Wright R. Viral antibodies and autoantibodies in chronic liver disease. Gut 1974, 15:94-98.
46. Vilagut L., Parés A., Viñas O., Vila J., de Anta MT Jiménez, Rodés J. Antibodies to mycobacterial 65 kD heat shock protein cross-react with the main mitochondrial antigens in patients with primary biliary cirrhosis. European Journal of Clinical Investigation 1997, 27:667-672.
47. Zandman-Goddard G., Berkun Y., Barzilai O., Boaz M., Blank M., Ram M., Sherer Y., Anaya J.M., Shoenfeld Y. Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease. Annals of the New York Academy of Sciences 2009, 1173:658-663.
48. Zinger H., Sherer Y., Goddard G., Berkun Y., Barzilai O., Agmon-Levin N., et al. Common infectious agents prevalence in antiphospholipid syndrome. Lupus 2009, 18:1149-1153.